What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications

Marta Serafini, Sarah Cargnin, Alberto Massarotti, Gian Cesare Tron, Tracey Pirali, Armando A. Genazzani

Risultato della ricerca: Contributo su rivistaArticolo di reviewpeer review

Abstract

The World Health Organization assigns international nonproprietary names (INN), also known as common names, to compounds upon request from drug developers. Structures of INNs are publicly available and represent a source, albeit underused, to understand trends in drug research and development. Here, we explain how a common drug name is composed and analyze chemical entities from 2000 to 2021. In the analysis, we describe some changes that intertwine chemical structure, newer therapeutic targets (e.g., kinases), including a significant increase in the use of fluorine and of heterocycles, and some other evolutionary modifications, such as the progressive increase in molecular weight. Alongside these, small signs of change can be spotted, such as the rise in spirocyclic scaffolds and small rings and the emergence of unconventional structural moieties that might forecast the future to come.

Lingua originaleInglese
pagine (da-a)4410-4429
Numero di pagine20
RivistaJournal of Medicinal Chemistry
Volume64
Numero di pubblicazione8
DOI
Stato di pubblicazionePubblicato - 22 apr 2021

Fingerprint

Entra nei temi di ricerca di 'What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications'. Insieme formano una fingerprint unica.

Cita questo